Acquisition Time-Informed Breast Tumor Segmentation from Dynamic Contrast-Enhanced MRI

arXiv — cs.CVFriday, November 21, 2025 at 5:00:00 AM
  • A new tumor segmentation method leveraging acquisition time in DCE
  • This development is significant as it aims to improve the reliability of tumor detection in breast cancer, which is essential for effective treatment planning and monitoring. Enhanced segmentation can lead to better patient outcomes and more personalized treatment strategies.
  • The innovation aligns with ongoing advancements in medical imaging, particularly in deep learning applications for tumor segmentation. As the field evolves, integrating temporal information and addressing algorithmic biases remain critical for improving diagnostic accuracy and reducing disparities in breast cancer detection.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended apps based on your readingExplore all apps
Continue Readings
Enhancing Breast Cancer Prediction with LLM-Inferred Confounders
PositiveArtificial Intelligence
A recent study has enhanced breast cancer prediction by utilizing large language models (LLMs) to infer the likelihood of confounding diseases such as diabetes, obesity, and cardiovascular disease from routine clinical data. This innovative approach has shown to improve the performance of Random Forest models, with notable enhancements from models like Gemma and Llama, indicating a significant advancement in predictive analytics for breast cancer.
A Goemans-Williamson type algorithm for identifying subcohorts in clinical trials
PositiveArtificial Intelligence
An efficient algorithm has been developed to identify predominantly homogeneous subcohorts of patients from large, inhomogeneous datasets, inspired by the Goemans-Williamson rounding technique. This algorithm has been applied to the RNA microarray dataset for breast cancer, revealing a potential link between LXR over-expression and BRCA2 and MSH6 methylation levels in specific patient subcohorts.
Exploring the added value of pretherapeutic MR descriptors in predicting breast cancer pathologic complete response to neoadjuvant chemotherapy
PositiveArtificial Intelligence
A recent study evaluated the association between pretreatment MRI descriptors and the pathologic complete response (pCR) of breast cancer patients undergoing neoadjuvant chemotherapy. The retrospective analysis included 129 patients treated between 2016 and 2020, revealing that 46% achieved pCR, with significant differences noted across breast cancer subtypes.